Impact of the Covid-19 pandemic on drug utilization and outcome measurements

Joint Basel Epidemiology Seminar and Basel Biometrics Society on

Impact of the Covid-19 pandemic on drug utilization and outcome measurements 

This seminar focuses on the impact of the COVID-19 pandemic on drug utilization and outcome measurements. After nearly 2 years in the pandemic, extensive real-world data has accumulated allowing deep insights into healthcare utilization at the population level and the patient’s journey across diseases within different healthcare systems. Understanding the change in healthcare utilization during the pandemic is essential for planning and interpreting observational studies covering this period of change.

The seminar is part of a joint BES & BBS seminar series about the importance of data and insight around the COVID-19 pandemic.